Association study on MTHFR polymorphisms and meningioma in northern China

Gene

Volumn 516, Issue 2, 2013, Pages 291-293

  Li, Ruiyan ^a   Wang, Rui ^a   Li, Yongli ^a   Li, Xianfeng ^a   Feng, Yan ^a   Li, Yongzhe ^a   Jiang, Chuanlu ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Association; Meningioma; MTHFR; Northern China; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CASE CONTROL STUDY; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873252046     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.019     Document Type: Article

References (22)

1. Bethke L., et al. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol. Biomark. Prev. 2008, 17:1195-1202.
2. Cui L.H., et al. Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med. Genet. 2011, 12:28.
3. Frosst P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10:111-113.
4. Galbiatti A.L., et al. Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell carcinoma risk. Mol. Biol. Rep. 2011, 39:635-645.
5. Kafadar A.M., et al. C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas. Anticancer Res. 2006, 26:2445-2449.
6. Kleihues P., Sobin L.H. World Health Organization classification of tumors. Cancer 2000, 88:2887.
7. Leone P.E., Mendiola M., Alonso J., Paz-y-Mino C., Pestana A. Implications of a RAD54L polymorphism (2290C/T) in human meningiomas as a risk factor and/or a genetic marker. BMC Cancer 2003, 3:6.
8. Lomas J., et al. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromosomes Cancer 2005, 42:314-319.
9. Lu C., Xie H., Wang F., Shen H., Wang J. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer 2011, 11:91.
10. Mao R., Fan Y., Chen F., Sun D., Bai J., Fu S. Methylenetetrahydrofolate reductase gene polymorphisms in 13 Chinese ethnic populations. Cell Biochem. Funct. 2008, 26:352-358.
11. Pecina-Slaus N., Nikuseva Martic T., Tomas D., Beros V., Zeljko M., Cupic H. Meningiomas exhibit loss of heterozygosity of the APC gene. J. Neurooncol 2008, 87:63-70.
12. Peters N., et al. Analysis of the PTEN gene in human meningiomas. Neuropathol. Appl. Neurobiol. 1998, 24:3-8.
13. Qu S., Sun D., Wang Y., Zhang C., Lv Y., Yao L. Association of ADAM33 polymorphisms with childhood asthma in a northern Chinese population. Exp. Mol. Pathol. 2011, 91:775-779.
14. Rajaraman P., et al. Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol. Biomarkers Prev. 2010, 19:1356-1361.
15. Rajaraman P., et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010, 12:37-48.
16. Reeves S.G., et al. MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Eur. J. Hum. Genet. 2009, 17:629-635.
17. Safarinejad M.R., Shafiei N., Safarinejad S. Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. Med. Oncol. 2010, 28(Suppl. 1):S398-S412.
18. Semmler A., Simon M., Moskau S., Linnebank M. Polymorphisms of methionine metabolism and susceptibility to meningioma formation: laboratory investigation. J. Neurosurg. 2008, 108:999-1004.
19. Sirachainan N., et al. Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children. Cancer Detect. Prev. 2008, 32:72-78.
20. van der Put N.M., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 1998, 62:1044-1051.
21. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 1998, 64:169-172.
22. Zang K.D. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet. Cell Genet. 2001, 93:207-220.